Skip to main content
. 2024 Jan-Mar;28(1):21–26. doi: 10.5935/1518-0557.20230066

Table 2.

Comparison of cycle outcome between GnRH agonist trigger and hCG trigger.

Variables Mean (SD) p-value
hCG (n=102) GnRH Agonist (n=107)
Total follicles on trigger day a 12.05 (6.18) 20.16 (9.29) <0.001 *c
Number of oocytes retrieved a 10.27 (6.10) 15.94 (7.96) <0.001 *c
Number of MII oocytes a 8.88 (5.93) 13.36 (7.47) <0.001 *c
Oocytes maturity rate (%) a 86.70 (15.54) 87.50 (13.00) 0.685 c
Number of oocytes inseminated a 8.88 (5.93) 13.36 (7.47) <0.001 *c
2PN a 6.82 (8.33) 9.19 (5.40) 0.015 *c
Fertilization rates (%) a 71.71 (18.99) 70.14 (19.01) 0.551 c
Total Embryo a 6.03 (4.05) 9.01 (5.40) <0.001 *c
Top quality embryo a 2.89 (3.15) 2.98 (3.44) 0.845 c
Embryo utilized a 5.14 (3.46) 6.62 (4.35) 0.007 *c
Embryo utilization rates (%) a 87.74 (16.50) 75.13 (21.29) <0.001 *c
Clinical pregnancy rate b 39 (38.2) 44 (41.1) 0.670 d
Ongoing pregnancy rate b 32 (31.4) 41 (38.3) 0.292 d
Miscarriage rates (%) a 5.23 (17.70) 2.65 (14.69) 0.254 c

HCG=human chorionic gonadotropin; GnRH=gonadotropin receptor hormone; BMI=body mass index; FSH=follicle stimulating hormone; LH=luteinizing hormone; AFC=atrial follicle count

*

p<0.05;

a

Data presented in mean (SD)

b

Data presented in frequency and percentage; n (%)

c

Independent T-test

d

Pearson’s Chi-Square Test